Health Canada drug identification number

DIN 02399202 — APO-BOSENTAN 62.5 MG

APO-BOSENTAN is a tablet of Bosentan marketed by APOTEX INC. The full Bosentan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02399202
Brand name
APO-BOSENTAN
Active ingredient
Bosentan
Strength
62.5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
APOTEX INC
Health Canada status
DORMANT
Drug class
Endothelin receptor antagonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Bosentan products

DINBrandStrengthFormManufacturerStatus
02399210 APO-BOSENTAN 125 MG TABLET APOTEX INC DORMANT
02467992 NAT-BOSENTAN 125 MG TABLET NATCO PHARMA (CANADA) INC DORMANT
02467984 NAT-BOSENTAN 62.5 MG TABLET NATCO PHARMA (CANADA) INC DORMANT
02383020 PMS-BOSENTAN 125 MG TABLET PHARMASCIENCE INC MARKETED
02383012 PMS-BOSENTAN 62.5 MG TABLET PHARMASCIENCE INC MARKETED
02483149 TARO-BOSENTAN 125 MG TABLET TARO PHARMACEUTICALS INC MARKETED
02483130 TARO-BOSENTAN 62.5 MG TABLET TARO PHARMACEUTICALS INC MARKETED
02244982 TRACLEER 125 MG TABLET JANSSEN INC MARKETED
02244981 TRACLEER 62.5 MG TABLET JANSSEN INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.